Pulse Biosciences reaches enrollment target in AF study
Pulse Biosciences said it achieved the enrollment target in its NANOPULSE-AF IDE pivotal clinical study evaluating the nPulse cardiac catheter system for atrial fibrillation treatment.
Pulse Biosciences said it achieved the enrollment target in its NANOPULSE-AF IDE pivotal clinical study evaluating the nPulse cardiac catheter system for atrial fibrillation treatment.